Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Consensus Rating of “Buy” by Analysts
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. […]
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. […]
